Why Tonix Pharmaceuticals Stock Is Soaring

Tonix Pharmaceuticals Holding Corp TNXP shares are trading higher Wednesday after the company announced that the United States Patent and Trademark Office issued a patent to Tonix titled, "Synthetic Chimeric Poxviruses."

The patent includes claims covering synthetic horsepox virus, the basis for the company's TNX-8011 vaccine in development to protect against monkeypox and smallpox and for the company's Recombinant Pox Virus platform to protect against other pathogens, including SARS-CoV-2.

"This patent is an important milestone in protecting our expanding pipeline of vaccines that address known and potentially novel pathogens," said Seth Lederman, CEO of Tonix.

The "Synthetic Chimeric Poxviruses" patent is expected to provide Tonix with U.S. market exclusivity until 2037.

After the market closed on Tuesday, Tonix also announced a $12.5 million share repurchase program. 

Tonix is a clinical-stage biopharmaceutical company focused on discovering, licensing, acquiring and developing therapeutics to treat and prevent human disease and alleviate suffering.

See Also: Morning Brief: Top Financial Stories Dominating on Wednesday, June 1

TNXP Price Action: Tonix shares are making new 52-week highs on Wednesday.

The stock was up 39.3% at $3.38 at press time, according to data from Benzinga Pro.

Photo: Michal Jarmoluk from Pixabay.

Posted In: NewsPenny StocksMoversTrading Ideas

Ad Disclosure: The rate information is obtained by Bankrate from the listed institutions. Bankrate cannot guaranty the accuracy or availability of any rates shown above. Institutions may have different rates on their own websites than those posted on Bankrate.com. The listings that appear on this page are from companies from which this website receives compensation, which may impact how, where, and in what order products appear. This table does not include all companies or all available products.

All rates are subject to change without notice and may vary depending on location. These quotes are from banks, thrifts, and credit unions, some of whom have paid for a link to their own Web site where you can find additional information. Those with a paid link are our Advertisers. Those without a paid link are listings we obtain to improve the consumer shopping experience and are not Advertisers. To receive the Bankrate.com rate from an Advertiser, please identify yourself as a Bankrate customer. Bank and thrift deposits are insured by the Federal Deposit Insurance Corp. Credit union deposits are insured by the National Credit Union Administration.

Consumer Satisfaction: Bankrate attempts to verify the accuracy and availability of its Advertisers' terms through its quality assurance process and requires Advertisers to agree to our Terms and Conditions and to adhere to our Quality Control Program. If you believe that you have received an inaccurate quote or are otherwise not satisfied with the services provided to you by the institution you choose, please click here.

Rate collection and criteria: Click here for more information on rate collection and criteria.